BIOMATERIALS BILL WITH BREAST IMPLANT EXCLUSION ACCEPTED BY HIMA BOARD
This article was originally published in The Gray Sheet
Executive Summary
Biomaterials liability legislation that excludes breast implants has the best chance of passage in the 105th Congress, the Health Industry Manufacturers Association has concluded. HIMA's board, meeting the week of Dec. 9, decided that work on biomaterials liability reform should begin in January where it ended in September: with a silicone breast implant "carve-out" that would exclude manufacturers of those products from liability protection under the bill.